RSS Feeds
Search

Companies

Companies

Displaying 1..1 of 1 - per page
Order by
Profiled on pharmalicensing.com National Jewish Health
The mission of National Jewish Health is to heal, to discover and to educate as a preeminent healthcare institution. More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Brentuximab Vedotin – First Treatment Option for Relapsed Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (Subset of Non-Hodgkin Lymphoma)
May 2011 - 5 pages - $500
US Oncology, Inc.: SWOT Analysis & Company Profile
Dec 2010 - 19 pages - $99
Follicular Lymphoma - Pipeline Review, Q3 2011
Jul 2011 - 213 pages - $500
Lymphoma - Pipeline Review, Q3 2011
Jul 2011 - 672 pages - $500
CNS Lymphoma - Pipeline Review, Q1 2011
Jan 2011 - 18 pages - $500
Burkitt Lymphoma - Pipeline Review, Q4 2010
Dec 2010 - 26 pages - $500
Mantle Cell Lymphoma - Pipeline Review, Q3 2011
Jul 2011 - 268 pages - $500
HIV-Related Lymphoma - Pipeline Review, Q1 2011
Jan 2011 - 18 pages - $500
Diffuse Large B-Cell Lymphoma - Pipeline Review, Q3 2011
Jul 2011 - 351 pages - $500
Cutaneous T-Cell Lymphoma - Pipeline Review, Q4 2010
Dec 2010 - 47 pages - $500
More Related Market Research Reports >>>

Your selection

Industry sector
Service del
Training del
Therapeutic target
Oncology del
Lymphoma del

Browse By

Therapeutic target
Hodgkin's lymphoma
Lymphoma, AIDS-related
Neoplastic disease
Non-Hodgkins lymphoma
Geographic location
Africa
Asia
Australia/New Zealand
Central America
Europe
Near & Far East
North America
South America

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us